The independent statistician for data monitoring committees
- 27 April 2004
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 23 (10), 1513-1517
- https://doi.org/10.1002/sim.1786
Abstract
Clinical trials are an essential part of the clinical research process. Recently, independent Data Monitoring Committees (DMCs) have been widely implemented to provide scientific and ethical oversight of pivotal clinical trials having irreversible outcomes such as death, stroke, disease recurrence or a serious adverse event. To carry out their responsibility, the DMC reviews interim analyses of accumulating data. We address the motivation for having the preparation and presentation of these interim analyses be conducted by an independent statistician who is not a member of the DMC and who is not the trial's lead or steering committee statistician. These views are based on having served as members of many DMCs as well as having been the independent statistician for several trials. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 12 references indexed in Scilit:
- Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?Statistics in Medicine, 2004
- Monitoring clinical trials: issues and controversies regarding confidentialityStatistics in Medicine, 2002
- The Role of an Independent Statistical Analysis Center in the Institutes of Health ModelDrug Information Journal, 2001
- Protecting Research Subjects — What Must Be DoneNew England Journal of Medicine, 2000
- The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trialsControlled Clinical Trials, 1995
- The case against independent monitoring committeesStatistics in Medicine, 1994
- The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.Circulation, 1994
- Organization, review, and administration of cooperative studies (greenberg report): A report from the heart special project committee to the National Advisory heart council, May 1967Controlled Clinical Trials, 1988
- Monitoring of the data for evidence of adverse or beneficial treatment effectsControlled Clinical Trials, 1983
- Practical aspects of decision making in clinical trials: The coronary drug project as a case studyControlled Clinical Trials, 1981